LVS vs OGEN · P/E 28, rev $2.90B vs rev $37.7K
Las Vegas Sands Corp (LVS) versus Oragenics Inc (OGEN) — a side-by-side from cached financials, not a winner call.
Las Vegas Sands Corp (LVS) is a resorts & casinos company listed on US.
Oragenics Inc (OGEN) is a biotechnology company listed on US.
Latest reported LVS revenue for 2024-12-31 was $2.90B. Net income was $392.0M. Revenue was up 8.0% from 2024-09-30 to 2024-12-31. LVS currently screens at market cap $35.70B and trailing P/E 28.3.
Latest reported OGEN revenue for 2023-12-31 was $37.7K. Net income was -$20.7M. Revenue was down 71.4% from 2022-12-31 to 2023-12-31. OGEN currently screens at market cap $2.7M.
LVS currently screens at market cap $35.70B and trailing P/E 28.3. OGEN currently screens at market cap $2.7M.
Not investment advice. Open the LVS and OGEN stock pages for the full models.
Not investment advice.